Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2007-09-04
2007-09-04
Chan, Christina (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S388150, C530S391700, C424S142100, C424S173100
Reexamination Certificate
active
10309764
ABSTRACT:
Antibodies which specifically recognize the human CD45 isoform RB are presented. These antibodies may be used to block undesirable immune reactions in patients with transplant rejection and autoimmune diseases such as rheumatoid arthritis, multiple sclerosis and autoimmune diabetes. Preferred antibodies are fully human, monoclonal antibodies.
REFERENCES:
patent: 6024957 (2000-02-01), Lazarovits et al.
patent: 6075181 (2000-06-01), Kucherlapati et al.
patent: 6099838 (2000-08-01), Lazarovits et al.
patent: 6106834 (2000-08-01), Lazarovits et al.
Rudikoff et al. Single amino acid substitution altering antigen-binding specificity. Proc. Natl. Acad. Sci. 1982; 79: 1979-1983.
Panka et al. Variable region framework differences result in decreased or increased affinity of variant anti-digoxin antibodies. Proc. Natl. Acad. Sci. 1988; 85: 3080-3084.
Schiffenbauer et al. Prevention of Experimental Allergic Encephalomyelitis by an antibody to CD45RB. Cellular Immunology, 1998; 190: 173-182.
Green et al. Antigen-specific human monoclonal antibodies from mice engineered with human lg heavy and light chain YACs. Nature Genetics, 1994; 7: 13-21.
Wroblewski et al. CD45-mediated signals can trigger shedding of lymphocyte L-selectin. International Immunology. 1996; 9: 555-562.
Babcook, et al., “A novel strategy for generating monoclonal antibodies from single, isolated lymphocytes producing antibodies of defined specificities”, Proc. Natl. Acad. Sci. USA, vol. 93, pp. 7843-7848, (Jul. 1996).
Green, et al., “Antigen-specific human monoclonal antibodies from mice engineered with human lg heavy and light chan YACs”, Nature Genetics, vol. 7, pp. 13-21, (May 1994).
Green, et al., “Regulation of B cell development by variable gene complexity in mice reconstituted with human immunoglobulin yeast artificial chromosomes”, J. Exp. Med., vol. 188, No. 3, pp. 483-495, (Aug. 3, 1998).
Lazarovits, et al., “Mechanisms of induction of renal allograft tolerance in DC45RB-treated mice”, Kidney Int., vol. 55, pp. 1303-1310, (1999).
Lazarovits, et al., “Prevention and reversal of renal allograft rejection by antibody against CD45RB”, Nature, vol. 380, pp. 717-720, (Apr. 25, 1996).
Mendez, et al., “Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice”, Nature Genetics, vol. 15, pp. 146-156, (Feb. 15, 1997).
Terskikh, et al., “‘Peptabody’: A new type of high avidity binding protein”, Biochemistry, vol. 94, pp. 1663-1668, (Mar. 1997).
Zhang, et al., “Prevention and reversal of renal allograft rejection by monoclonal antibody to CD45RB in the mouse model”, Transplant Proc., vol. 27, No. 1, pp. 389-3826, (1995).
Basadonna, et al., “Antibody-mediated targeting of CD45 isoforms: A novel immunotherapeutic strategy”, Proc. Natl. Acad. Sci. USA, vol. 95, pp. 3821-3826, (Mar. 1998).
International Preliminary Examination Report mailed on Mar. 23, 2005.
Luke et al., “Anti-CD45RB Monoclonal Antibody-Mediated Transplantation Tolerance,”Current Molecular Medicine, 2001, 1, 533-543.
Zhong et al., “Monoclonal antibody against CD45RB for the therapy of rejection and autoimmune diseases,”J. Mol. Med., 1998, 76: 527-580.
Supplementary Partial European Search Report under Rule 46, paragraph 1 of the European Patent Convention, Application No. EP 02 78 6850.
Babcook John S.
Foltz Ian
King Chadwick T.
Palathumpat Varghese
Yang Xiao-Dong
Amgen Fremont Inc.
Chan Christina
Skelding Zachary
LandOfFree
Anti-CD45RB antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-CD45RB antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-CD45RB antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3729419